The global implantable collamer lens market is set to experience remarkable expansion in the coming decade, driven by the increasing adoption of minimally invasive vision correction procedures. Market ...

Bronstein, Gewirtz & Grossman, LLC is currently investigating potential claims on behalf of purchasers of Bausch + Lomb (NYSE ...

J.P. Morgan analysts said it was too early to discuss the financial impact of the recall, but estimated that $70 million to ...

Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a "voluntary recall" of ...

Here are some of the top stories moving markets midday Friday. The "Magnificent Seven" are part of the reason stocks are ...

Eye health company Bausch + Lomb has issued a voluntary recall of a series of intraocular lenses, according to a March 27 ...

Alcon is one of the leading visioncare companies in the world, with a record of successful product development, and it will continue to launch technically superior products.

Bausch + Lomb has voluntarily recalled IOLs included on its enVista platform, including enVista Aspire, enVista Envy and ...

Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, ...

Bausch + Lomb has initiated a voluntary recall of its enVista platform intraocular lenses (IOLs) following reports of TASS.

Most cases of TASS can be treated with steroids within a few days, although severe cases can lead to permanent damage to the ...

Bausch + Lomb has reported a “voluntary recall” of certain intraocular lenses (IOLs) on its enVista platform due to ...